{'fraction_non_alphanumeric': 0.025691699604743084, 'fraction_numerical': 0.0029644268774703555, 'mean_word_length': 6.034722222222222, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Synthesis of a rhodium complex bearing a chiral nitrogen-based ligand for asymmetric hydrogenation.

Asymmetric hydrogenation of prochiral molecules by chiral metal complexes has emerged as a useful synthetic tool for the preparation of single enantiomer molecules and has diverse application in a variety of industries, including pharmaceuticals. To date, most catalytic systems for asymmetric hydrogenation are supported by phosphine ligands. Thus, chiral nitrogen-based ligands provide an opportunity to investigate a relatively underexplored area of hydrogenation chemistry. To this end, we are investigating rhodium complexes supported by chiral nitrogen-based ligands. The synthesis of a previously reported chiral nitrogen ligand (R,R)-2,6-bis[1-(N-piperidinyl)ethyl]pyridine has been achieved through a modified synthetic procedure and characterized by NMR spectroscopy. Attempts to synthesize our target rhodium complex in order to investigate asymmetric hydrogenation reactivity are currently underway.